NCT06846905View on ClinicalTrials.gov

Cost-utility Analysis of Ambulatory Dose Escalation of Bispecific Antibodies in Multiple Myeloma.

RecruitingOBSERVATIONAL

Enrollment

40

Participants

Timeline

Start Date

January 20, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2026

Conditions

Multiple Myeloma in Relapse

Trial Locations (1)

31100

RECRUITING

CHU de Toulouse, Toulouse

All Listed Sponsors

lead

University Hospital, Toulouse

OTHER